Report cover image

Global Peanut Allergy Therapeutics Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Aug 16, 2025
Length 203 Pages
SKU # APRC20361116

Description

Summary

According to APO Research, The global Peanut Allergy Therapeutics market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Peanut Allergy Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Peanut Allergy Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Peanut Allergy Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Peanut Allergy Therapeutics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Peanut Allergy Therapeutics include Aimmune Therapeutics, ALK Abello, Allergy Therapeutics, Amneal Pharma, ASIT Biotech, DBV Technologies, HAL Allergy, Intrommune Therapeutics and Kaleo, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Peanut Allergy Therapeutics, market size. Analyses of the global market trends, with historic market revenue data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Peanut Allergy Therapeutics, also provides the revenue of main regions and countries. Of the upcoming market potential for Peanut Allergy Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Peanut Allergy Therapeutics revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Peanut Allergy Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2020 to 2031. Evaluation and forecast the market size for Peanut Allergy Therapeutics revenue, projected growth trends, production technology, application and end-user industry.

Peanut Allergy Therapeutics Segment by Company

Aimmune Therapeutics
ALK Abello
Allergy Therapeutics
Amneal Pharma
ASIT Biotech
DBV Technologies
HAL Allergy
Intrommune Therapeutics
Kaleo
Perrigo
UCB Pharma
Bayer
GSK
Mylan
J & J
Sanofi
HUAPONT Pharm
Peanut Allergy Therapeutics Segment by Type

Epinephrine Injection
Oral Immunotherapy
Antihistamines
Other
Peanut Allergy Therapeutics Segment by Application

Hospital Pharmacy
Retail Pharmacy
Other
Peanut Allergy Therapeutics Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Peanut Allergy Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Peanut Allergy Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Peanut Allergy Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Peanut Allergy Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Peanut Allergy Therapeutics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Peanut Allergy Therapeutics revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Table of Contents

203 Pages
1 Market Overview
1.1 Product Definition
1.2 Peanut Allergy Therapeutics Market by Type
1.2.1 Global Peanut Allergy Therapeutics Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Epinephrine Injection
1.2.3 Oral Immunotherapy
1.2.4 Antihistamines
1.2.5 Other
1.3 Peanut Allergy Therapeutics Market by Application
1.3.1 Global Peanut Allergy Therapeutics Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Peanut Allergy Therapeutics Market Dynamics
2.1 Peanut Allergy Therapeutics Industry Trends
2.2 Peanut Allergy Therapeutics Industry Drivers
2.3 Peanut Allergy Therapeutics Industry Opportunities and Challenges
2.4 Peanut Allergy Therapeutics Industry Restraints
3 Global Growth Perspective
3.1 Global Peanut Allergy Therapeutics Market Perspective (2020-2031)
3.2 Global Peanut Allergy Therapeutics Growth Trends by Region
3.2.1 Global Peanut Allergy Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
3.2.2 Global Peanut Allergy Therapeutics Market Size by Region (2020-2025)
3.2.3 Global Peanut Allergy Therapeutics Market Size by Region (2026-2031)
4 Competitive Landscape by Players
4.1 Global Peanut Allergy Therapeutics Revenue by Players
4.1.1 Global Peanut Allergy Therapeutics Revenue by Players (2020-2025)
4.1.2 Global Peanut Allergy Therapeutics Revenue Market Share by Players (2020-2025)
4.1.3 Global Peanut Allergy Therapeutics Players Revenue Share Top 10 and Top 5 in 2024
4.2 Global Peanut Allergy Therapeutics Key Players Ranking, 2023 VS 2024 VS 2025
4.3 Global Peanut Allergy Therapeutics Key Players Headquarters & Area Served
4.4 Global Peanut Allergy Therapeutics Players, Product Type & Application
4.5 Global Peanut Allergy Therapeutics Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Peanut Allergy Therapeutics Market CR5 and HHI
4.6.3 2024 Peanut Allergy Therapeutics Tier 1, Tier 2, and Tier 3
5 Peanut Allergy Therapeutics Market Size by Type
5.1 Global Peanut Allergy Therapeutics Revenue by Type (2020 VS 2024 VS 2031)
5.2 Global Peanut Allergy Therapeutics Revenue by Type (2020-2031)
5.3 Global Peanut Allergy Therapeutics Revenue Market Share by Type (2020-2031)
6 Peanut Allergy Therapeutics Market Size by Application
6.1 Global Peanut Allergy Therapeutics Revenue by Application (2020 VS 2024 VS 2031)
6.2 Global Peanut Allergy Therapeutics Revenue by Application (2020-2031)
6.3 Global Peanut Allergy Therapeutics Revenue Market Share by Application (2020-2031)
7 Company Profiles
7.1 Aimmune Therapeutics
7.1.1 Aimmune Therapeutics Comapny Information
7.1.2 Aimmune Therapeutics Business Overview
7.1.3 Aimmune Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
7.1.4 Aimmune Therapeutics Peanut Allergy Therapeutics Product Portfolio
7.1.5 Aimmune Therapeutics Recent Developments
7.2 ALK Abello
7.2.1 ALK Abello Comapny Information
7.2.2 ALK Abello Business Overview
7.2.3 ALK Abello Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
7.2.4 ALK Abello Peanut Allergy Therapeutics Product Portfolio
7.2.5 ALK Abello Recent Developments
7.3 Allergy Therapeutics
7.3.1 Allergy Therapeutics Comapny Information
7.3.2 Allergy Therapeutics Business Overview
7.3.3 Allergy Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
7.3.4 Allergy Therapeutics Peanut Allergy Therapeutics Product Portfolio
7.3.5 Allergy Therapeutics Recent Developments
7.4 Amneal Pharma
7.4.1 Amneal Pharma Comapny Information
7.4.2 Amneal Pharma Business Overview
7.4.3 Amneal Pharma Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
7.4.4 Amneal Pharma Peanut Allergy Therapeutics Product Portfolio
7.4.5 Amneal Pharma Recent Developments
7.5 ASIT Biotech
7.5.1 ASIT Biotech Comapny Information
7.5.2 ASIT Biotech Business Overview
7.5.3 ASIT Biotech Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
7.5.4 ASIT Biotech Peanut Allergy Therapeutics Product Portfolio
7.5.5 ASIT Biotech Recent Developments
7.6 DBV Technologies
7.6.1 DBV Technologies Comapny Information
7.6.2 DBV Technologies Business Overview
7.6.3 DBV Technologies Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
7.6.4 DBV Technologies Peanut Allergy Therapeutics Product Portfolio
7.6.5 DBV Technologies Recent Developments
7.7 HAL Allergy
7.7.1 HAL Allergy Comapny Information
7.7.2 HAL Allergy Business Overview
7.7.3 HAL Allergy Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
7.7.4 HAL Allergy Peanut Allergy Therapeutics Product Portfolio
7.7.5 HAL Allergy Recent Developments
7.8 Intrommune Therapeutics
7.8.1 Intrommune Therapeutics Comapny Information
7.8.2 Intrommune Therapeutics Business Overview
7.8.3 Intrommune Therapeutics Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
7.8.4 Intrommune Therapeutics Peanut Allergy Therapeutics Product Portfolio
7.8.5 Intrommune Therapeutics Recent Developments
7.9 Kaleo
7.9.1 Kaleo Comapny Information
7.9.2 Kaleo Business Overview
7.9.3 Kaleo Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
7.9.4 Kaleo Peanut Allergy Therapeutics Product Portfolio
7.9.5 Kaleo Recent Developments
7.10 Perrigo
7.10.1 Perrigo Comapny Information
7.10.2 Perrigo Business Overview
7.10.3 Perrigo Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
7.10.4 Perrigo Peanut Allergy Therapeutics Product Portfolio
7.10.5 Perrigo Recent Developments
7.11 UCB Pharma
7.11.1 UCB Pharma Comapny Information
7.11.2 UCB Pharma Business Overview
7.11.3 UCB Pharma Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
7.11.4 UCB Pharma Peanut Allergy Therapeutics Product Portfolio
7.11.5 UCB Pharma Recent Developments
7.12 Bayer
7.12.1 Bayer Comapny Information
7.12.2 Bayer Business Overview
7.12.3 Bayer Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
7.12.4 Bayer Peanut Allergy Therapeutics Product Portfolio
7.12.5 Bayer Recent Developments
7.13 GSK
7.13.1 GSK Comapny Information
7.13.2 GSK Business Overview
7.13.3 GSK Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
7.13.4 GSK Peanut Allergy Therapeutics Product Portfolio
7.13.5 GSK Recent Developments
7.14 Mylan
7.14.1 Mylan Comapny Information
7.14.2 Mylan Business Overview
7.14.3 Mylan Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
7.14.4 Mylan Peanut Allergy Therapeutics Product Portfolio
7.14.5 Mylan Recent Developments
7.15 J & J
7.15.1 J & J Comapny Information
7.15.2 J & J Business Overview
7.15.3 J & J Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
7.15.4 J & J Peanut Allergy Therapeutics Product Portfolio
7.15.5 J & J Recent Developments
7.16 Sanofi
7.16.1 Sanofi Comapny Information
7.16.2 Sanofi Business Overview
7.16.3 Sanofi Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
7.16.4 Sanofi Peanut Allergy Therapeutics Product Portfolio
7.16.5 Sanofi Recent Developments
7.17 HUAPONT Pharm
7.17.1 HUAPONT Pharm Comapny Information
7.17.2 HUAPONT Pharm Business Overview
7.17.3 HUAPONT Pharm Peanut Allergy Therapeutics Revenue and Gross Margin (2020-2025)
7.17.4 HUAPONT Pharm Peanut Allergy Therapeutics Product Portfolio
7.17.5 HUAPONT Pharm Recent Developments
8 North America
8.1 North America Peanut Allergy Therapeutics Revenue (2020-2031)
8.2 North America Peanut Allergy Therapeutics Revenue by Type (2020-2031)
8.2.1 North America Peanut Allergy Therapeutics Revenue by Type (2020-2025)
8.2.2 North America Peanut Allergy Therapeutics Revenue by Type (2026-2031)
8.3 North America Peanut Allergy Therapeutics Revenue Share by Type (2020-2031)
8.4 North America Peanut Allergy Therapeutics Revenue by Application (2020-2031)
8.4.1 North America Peanut Allergy Therapeutics Revenue by Application (2020-2025)
8.4.2 North America Peanut Allergy Therapeutics Revenue by Application (2026-2031)
8.5 North America Peanut Allergy Therapeutics Revenue Share by Application (2020-2031)
8.6 North America Peanut Allergy Therapeutics Revenue by Country
8.6.1 North America Peanut Allergy Therapeutics Revenue by Country (2020 VS 2024 VS 2031)
8.6.2 North America Peanut Allergy Therapeutics Revenue by Country (2020-2025)
8.6.3 North America Peanut Allergy Therapeutics Revenue by Country (2026-2031)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Peanut Allergy Therapeutics Revenue (2020-2031)
9.2 Europe Peanut Allergy Therapeutics Revenue by Type (2020-2031)
9.2.1 Europe Peanut Allergy Therapeutics Revenue by Type (2020-2025)
9.2.2 Europe Peanut Allergy Therapeutics Revenue by Type (2026-2031)
9.3 Europe Peanut Allergy Therapeutics Revenue Share by Type (2020-2031)
9.4 Europe Peanut Allergy Therapeutics Revenue by Application (2020-2031)
9.4.1 Europe Peanut Allergy Therapeutics Revenue by Application (2020-2025)
9.4.2 Europe Peanut Allergy Therapeutics Revenue by Application (2026-2031)
9.5 Europe Peanut Allergy Therapeutics Revenue Share by Application (2020-2031)
9.6 Europe Peanut Allergy Therapeutics Revenue by Country
9.6.1 Europe Peanut Allergy Therapeutics Revenue by Country (2020 VS 2024 VS 2031)
9.6.2 Europe Peanut Allergy Therapeutics Revenue by Country (2020-2025)
9.6.3 Europe Peanut Allergy Therapeutics Revenue by Country (2026-2031)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Netherlands
10 China
10.1 China Peanut Allergy Therapeutics Revenue (2020-2031)
10.2 China Peanut Allergy Therapeutics Revenue by Type (2020-2031)
10.2.1 China Peanut Allergy Therapeutics Revenue by Type (2020-2025)
10.2.2 China Peanut Allergy Therapeutics Revenue by Type (2026-2031)
10.3 China Peanut Allergy Therapeutics Revenue Share by Type (2020-2031)
10.4 China Peanut Allergy Therapeutics Revenue by Application (2020-2031)
10.4.1 China Peanut Allergy Therapeutics Revenue by Application (2020-2025)
10.4.2 China Peanut Allergy Therapeutics Revenue by Application (2026-2031)
10.5 China Peanut Allergy Therapeutics Revenue Share by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Peanut Allergy Therapeutics Revenue (2020-2031)
11.2 Asia Peanut Allergy Therapeutics Revenue by Type (2020-2031)
11.2.1 Asia Peanut Allergy Therapeutics Revenue by Type (2020-2025)
11.2.2 Asia Peanut Allergy Therapeutics Revenue by Type (2026-2031)
11.3 Asia Peanut Allergy Therapeutics Revenue Share by Type (2020-2031)
11.4 Asia Peanut Allergy Therapeutics Revenue by Application (2020-2031)
11.4.1 Asia Peanut Allergy Therapeutics Revenue by Application (2020-2025)
11.4.2 Asia Peanut Allergy Therapeutics Revenue by Application (2026-2031)
11.5 Asia Peanut Allergy Therapeutics Revenue Share by Application (2020-2031)
11.6 Asia Peanut Allergy Therapeutics Revenue by Country
11.6.1 Asia Peanut Allergy Therapeutics Revenue by Country (2020 VS 2024 VS 2031)
11.6.2 Asia Peanut Allergy Therapeutics Revenue by Country (2020-2025)
11.6.3 Asia Peanut Allergy Therapeutics Revenue by Country (2026-2031)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Peanut Allergy Therapeutics Revenue (2020-2031)
12.2 SAMEA Peanut Allergy Therapeutics Revenue by Type (2020-2031)
12.2.1 SAMEA Peanut Allergy Therapeutics Revenue by Type (2020-2025)
12.2.2 SAMEA Peanut Allergy Therapeutics Revenue by Type (2026-2031)
12.3 SAMEA Peanut Allergy Therapeutics Revenue Share by Type (2020-2031)
12.4 SAMEA Peanut Allergy Therapeutics Revenue by Application (2020-2031)
12.4.1 SAMEA Peanut Allergy Therapeutics Revenue by Application (2020-2025)
12.4.2 SAMEA Peanut Allergy Therapeutics Revenue by Application (2026-2031)
12.5 SAMEA Peanut Allergy Therapeutics Revenue Share by Application (2020-2031)
12.6 SAMEA Peanut Allergy Therapeutics Revenue by Country
12.6.1 SAMEA Peanut Allergy Therapeutics Revenue by Country (2020 VS 2024 VS 2031)
12.6.2 SAMEA Peanut Allergy Therapeutics Revenue by Country (2020-2025)
12.6.3 SAMEA Peanut Allergy Therapeutics Revenue by Country (2026-2031)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.